AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2015
Sep 8, 2015
34301_dirs_2015-09-08_65e9737d-dd77-4840-8fca-ff65715dfdbf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2015-09-03
Reporting Person: Thompson Tommy G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-03 | Common Stock | P | 25449 | $0.3745 | Acquired | 83600 | Indirect |
Footnotes
F1: These securities are owned by the Thompson Family LLC.
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
Jun 18
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Call Transcript
2026
May 14
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9